How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison? In...
Read More
Discover how data visualisation dashboards can aid field teams in market access discussions with customers Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with...
Read More
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the...
Read More
What is health economic evaluation and which modelling approaches can be used to support market access activities? In this webinar, our expert health economists explain the key strengths and limitations...
Read More
In this live lecture, Hannah Baker (Consultant – Health Economics) outlines the role health economics plays in modern healthcare.
In this webinar, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
Our experts in health economics, value communication, design and digital discussed how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
Are you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could...
Read More
